Regina Esser

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer

Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello et al. · JAMA Oncology · 2016 · 722 citations · Full text

Medicine, Cancer Biology, Oncology +17

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies

Lisa Licitra, Stephan Störkel, Keith M. Kerr et al. · European Journal of Cancer · 2012 · 171 citations

Medicine, Oncology, Pharmacology +17

Cetuximab Plus Irinotecan in Heavily Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: MABEL Study

H. Wilke, Rob Glynne‐Jones, Josef Thaler et al. · Journal of Clinical Oncology · 2008 · 103 citations · Full text

Medicine, Oncology, Pharmacology +14

Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients

Fortunato Ciardiello, Richard Adams, Josep Tabernero et al. · The Oncologist · 2016 · 53 citations · Full text

Medicine, Oncology, Medical Oncology +16

Reduced incidence of infusion‐related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication

Salvatore Siena, Rob Glynne‐Jones, Antoine Adenis et al. · Cancer · 2010 · 49 citations

Medicine, Oncology, Pharmacology +17